Congratulations to the Immunity Project team! 

Over the weekend we learned that Vaccine published our article on eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL/6 mouse model using peptide-containing biodegradable microspheres and adjuvants.  In layperson terms, this article covers the work we did in partnership with Microsoft Research to show that our biodegradable microsphere based vaccine can elicit an immune response in mice.  Download a PDF of our article or view it online at Science Direct.

This is a big step forward for us.  Our mission at Immunity Project is to develop a free HIV vaccine.  In order to do this we need to prove that our experimental data supports our approach every step of the way.  A great way for us to do this is to publish our work in a respected peer reviewed journal such as Vaccine.